Wednesday, February 7, 2018

Redefined Alzheimer's biology has implications for drug design

Redefined Alzheimer's biology has implications for drug design:

Dementia Big
Despite the 25-year focus on the build-up in brain tissues of one protein, amyloid beta, as the purported origin of Alzheimer’s disease (AD), a new study argues that it is likely triggered instead by the failure of a system that clears wastes from the brain - and actually begins decades before memories fade.


http://ift.tt/2FXbIoB

No comments:

Post a Comment